Clínica Las Condes S.A.

SNSE:LAS CONDES Stock Report

Market Cap: CL$90.8b

Clínica Las Condes Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Clínica Las Condes.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth26.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Jul 02
Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Apr 30
Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Clínica Las Condes S.A.'s (SNSE:LAS CONDES) Business Is Yet to Catch Up With Its Share Price

Mar 28
Clínica Las Condes S.A.'s (SNSE:LAS CONDES) Business Is Yet to Catch Up With Its Share Price

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Jan 12
Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Oct 24
Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Returns At Clínica Las Condes (SNSE:LAS CONDES) Are On The Way Up

Sep 27
Returns At Clínica Las Condes (SNSE:LAS CONDES) Are On The Way Up

Clínica Las Condes (SNSE:LAS CONDES) Is Experiencing Growth In Returns On Capital

Jun 21
Clínica Las Condes (SNSE:LAS CONDES) Is Experiencing Growth In Returns On Capital

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

May 19
Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

Clínica Las Condes (SNSE:LAS CONDES) Is Doing The Right Things To Multiply Its Share Price

Aug 25
Clínica Las Condes (SNSE:LAS CONDES) Is Doing The Right Things To Multiply Its Share Price

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Apr 20
There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Is Clínica Las Condes (SNSE:LAS CONDES) Using Too Much Debt?

Mar 10
Is Clínica Las Condes (SNSE:LAS CONDES) Using Too Much Debt?

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Oct 07
There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

A Look At The Fair Value Of Clínica Las Condes S.A. (SNSE:LAS CONDES)

Aug 28
A Look At The Fair Value Of Clínica Las Condes S.A. (SNSE:LAS CONDES)

Does Clínica Las Condes (SNSE:LAS CONDES) Have A Healthy Balance Sheet?

May 31
Does Clínica Las Condes (SNSE:LAS CONDES) Have A Healthy Balance Sheet?

Some Investors May Be Worried About Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Apr 16
Some Investors May Be Worried About Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

A Look At Clínica Las Condes' (SNSE:LAS CONDES) Share Price Returns

Mar 12
A Look At Clínica Las Condes' (SNSE:LAS CONDES) Share Price Returns

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

Feb 05
Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

Should You Be Impressed By Clínica Las Condes' (SNSE:LAS CONDES) Returns on Capital?

Jan 01
Should You Be Impressed By Clínica Las Condes' (SNSE:LAS CONDES) Returns on Capital?

Clínica Las Condes'(SNSE:LAS CONDES) Share Price Is Down 36% Over The Past Five Years.

Nov 27
Clínica Las Condes'(SNSE:LAS CONDES) Share Price Is Down 36% Over The Past Five Years.

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Clínica Las Condes has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SNSE:LAS CONDES - Analysts future estimates and past financials data (CLP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2024186,744-10,078-5,668-3,257N/A
6/30/2024196,410-2,9772,7295,996N/A
3/31/2024198,852-2,1468,11012,433N/A
12/31/2023202,263-3,4017,99113,589N/A
9/30/2023211,636-8,99810,54218,272N/A
6/30/2023225,539-1,24026,21135,639N/A
3/31/2023245,36064737,11347,320N/A
12/31/2022259,9924,04737,20549,213N/A
9/30/2022271,37193947,30858,684N/A
6/30/2022279,9438,91636,05246,376N/A
3/31/2022282,38913,36239,36149,566N/A
12/31/2021276,85418,41729,90037,601N/A
9/30/2021269,27928,62225,32230,999N/A
6/30/2021248,85719,43718,13622,066N/A
3/31/2021220,6594,9336443,216N/A
12/31/2020212,266-5,28011,62215,822N/A
9/30/2020202,808-12,09510,11415,277N/A
6/30/2020209,306-7,45118,59024,333N/A
3/31/2020224,8601,75022,40529,031N/A
12/31/2019226,1945,21915,66020,066N/A
9/30/2019227,9658,37525,81529,195N/A
6/30/2019226,0877,08127,98930,625N/A
3/31/2019224,1194,77813,99216,806N/A
12/31/2018219,4004,50510,23716,241N/A
9/30/2018206,418-4,6767,36716,168N/A
6/30/2018203,297-5,581N/A8,939N/A
3/31/2018198,778-5,100N/A24,030N/A
12/31/2017194,920-10,346N/A25,341N/A
9/30/2017195,766-9,252N/A21,246N/A
6/30/2017199,616-5,559N/A8,245N/A
3/31/2017197,397-3,258N/A3,253N/A
12/31/2016196,4731,500N/A-7,191N/A
9/30/2016195,8065,303N/A-20,704N/A
6/30/2016188,9045,370N/A-4,569N/A
3/31/2016183,3054,374N/A-5,973N/A
12/31/2015178,0545,270N/A428N/A
9/30/2015174,0077,929N/A9,025N/A
6/30/2015165,9739,217N/A14,562N/A
3/31/2015160,60412,272N/A15,747N/A
12/31/2014156,38614,227N/A22,725N/A
9/30/2014151,77217,275N/A24,894N/A
6/30/2014146,84017,629N/A21,381N/A
3/31/2014142,83718,135N/A23,327N/A
12/31/2013138,85118,104N/A20,125N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if LAS CONDES's forecast earnings growth is above the savings rate (5.5%).

Earnings vs Market: Insufficient data to determine if LAS CONDES's earnings are forecast to grow faster than the CL market

High Growth Earnings: Insufficient data to determine if LAS CONDES's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if LAS CONDES's revenue is forecast to grow faster than the CL market.

High Growth Revenue: Insufficient data to determine if LAS CONDES's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if LAS CONDES's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 14:32
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Clínica Las Condes S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution